Incyte Corp. sell BMO Capital Markets
Start price
30.07.25
/
50%
€67.88
Target price
30.07.26
€51.87
Performance (%)
57.93%
End price
31.07.26
€107.20
Summary
This prediction ended on 31.07.26 with a price of €107.20. The price for Incyte Corp. massively increased, which is bad news for the SELL prediction by BMO_Capital_Markets. BMO_Capital_Markets has a follow-up prediction for Incyte Corp. where he still thinks Incyte Corp. is a Sell. BMO_Capital_Markets has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Incyte Corp. | -1.625% | -1.625% | 57.484% |
| iShares Core DAX® | 2.334% | 1.011% | 10.406% |
| iShares Nasdaq 100 | 1.370% | -3.612% | 27.400% |
| iShares Nikkei 225® | 2.437% | -7.461% | 49.840% |
| iShares S&P 500 | 1.259% | 0.677% | 23.666% |
Comments by BMO_Capital_Markets for this prediction
In the thread Incyte Corp. diskutieren
Incyte Corporation (NASDAQ: INCY) had its price target raised by analysts at BMO Capital Markets from $52.00 to $60.00. They now have an "underperform" rating on the stock.
Ratings data for INCY provided by MarketBeat
In the thread Trading Incyte Corp.
Die von BMO_Capital_Markets gewählte maximale Laufzeit wurde überschritten